These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: Steroid antagonists and receptor-associated proteins.
    Author: Lebeau MC, Baulieu EE.
    Journal: Hum Reprod; 1994 Mar; 9(3):437-44. PubMed ID: 8006131.
    Abstract:
    In research to control human reproduction, after the discovery of the progesterone receptor, an idea emerged about a molecule that could compete with progesterone for its binding site on the receptor, and at the same time block the receptor in a non-functional conformation to prevent or even terminate pregnancy. Among new progesterone antagonists tested, Roussel-UCLAF's RU-486 or mifepristone was the most fascinating. Currently in France (in 1993), a woman pays 4 visits over a 3-week period in a licensed hospital to terminate an unwanted pregnancy. She is given 3 x 200 mg pills of RU-486. 48 hours later, she receives the oral prostaglandin Misoprostol (2 x 200 mcg). She remains for 4 hours at the center, during which time 70% of the women abort. If expulsion does not occur, a third Misoprostol 200 mcg tablet is given. A fourth control visit takes place 10-15 days later. This protocol achieved 98% efficacy in pregnancies of 49 days of amenorrhea, but it is currently not applicable to heavy smokers or women over 35 years old. Other uses for RU-486: 1) Cervical ripening in second or third trimester abortions with a dose of 200-600 mg RU-486. 2) Initiation of labor in women for medical indications. 3) Contraception: a) late luteal postcoital administration of 400 or 600 mg RU-486 once or twice for 2 days before menses, b) monthly late luteal phase, premenstrual administration of a low-dose of RU-486 plus Misoprostol 2 days before menses, c) emergency postcoital contraception in a single 600 mg dose after unprotected intercourse within 72 hours, d) once a month anti-implantation with 200 mg of RU-486 given 2 days after unprotected intercourse, e) suppression of ovulation, f) endometrial contraception. After more than 10 years of administration to more than 150,000 women, RU-486, particularly in association with Misoprostol, is an excellent and safe agent for termination of pregnancy under the mandatory supervision of a physician.
    [Abstract] [Full Text] [Related] [New Search]